Naperville, IL -- (SBWire) -- 11/10/2014 --Reportstack, provider of premium market research reports announces the addition of Global Cardiac Biomarkers Market 2014-2018 market report to its offering
About Cardiac Biomarker
A cardiac biomarker is defined as a measurable substance that is an indicator used in the diagnosis and risk stratification related to cardiovascular disease (CVDs) such as acute coronary syndrome (ACS), coronary syndromes, myocardial infarction (MI), and heart failure. Some of the cardiac biomarkers include creatine kinase (CK) MB, troponins (cTnI and cTnT), BNP, NT-proBNP, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, and sCD40L. Cardiac biomarker assays help medical professionals to understand and differentiate between myocardial infarction and angina, which assists in the diagnosis and treatment of CVDs. The abnormal concentration of these biomarkers will act as significant predictors of an adverse cardiovascular condition. Cardiac point of care (POC) testing offers reliable measurement of cardiac biomarkers and provides results within one hour of testing. In addition to saving time, some cardiac POC tests have been modified to improve the accuracy of the measurement of enzymes to reduce operational error.
Analysts forecast the Global Cardiac Biomarkers market to grow at a CAGR of 12.75 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Cardiac Biomarkers market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of devices and assays used for cardiac biomarkers to diagnose various cardiovascular diseases.
The market is segmented based on the following type of assay:
- Troponin (cTnI and cTnT)
- BNP & NT-proBNP
- CK-MB
- Myogloblin
- Others (hs-CRP, D-Dimer, GFAP, H-FABP, LDH isoenzymes, D-dimer, IMA, MPO, myoglobin, AST, FFAu, and sCD40L)
Global Cardiac Biomarkers Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cardiac Biomarkers market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions:
- Americas
- APAC
- EMEA
Key Vendors:
- Abbott Laboratories
- Alere
- Ortho Clinical Diagnostics
- Roche Diagnostics
Other Prominent Vendors:
- AniBiotech
- Axis-Shield
- Beckman Coulter
- Becton, Dickinson and Co.
- BG Medicine
- Biomerieux
- Boston Scientific
- Critical Diagnostics
- diaDexus
- LifeSign
- Mitsubishi Chemical Europe
- Nanomix
- Radiometer Medical
- Randox Laboratories
- Response Biomedical
- Siemens Healthcare
- Sierra Resources International
- Singulex
- Thermo Scientific
- Trinity Biotech
Market Driver:
- Growing Incidence of Cardiac Disorders
- For a full, detailed list, view our report
Market Challenge:
- Lack of Specific Measures to Detect Presence of CVDs
- For a full, detailed list, view our report
Market Trend:
- Identification of New Cardiac Biomarkers
- For a full, detailed list, view our report
Key Questions Answered in this Report:
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Complete report is available
http://www.reportstack.com/product/183431/global-cardiac-biomarkers-market-2014-2018.html
Contact:
Roger Campbell
roger@reportstack.com
Naperville
Illinois
United States
Ph: 888-789-6604
Global Cardiac Biomarkers Market 2014-2018